125 related articles for article (PubMed ID: 195708)
1. Cellular immunity to herpes simplex virus in man. VII. K-cell activity to HSV1 infected target cells in disease.
Russell AS; Essery G
Cancer; 1977 Jul; 40(1):42-5. PubMed ID: 195708
[TBL] [Abstract][Full Text] [Related]
2. Cell-mediated immunity to herpes simplex virus in man. V. Antibody-mediated cell-dependent immune lysis of herpes virus-infected target cells.
Russell AS; Kaiser JT
J Allergy Clin Immunol; 1976 Nov; 58(5):539-45. PubMed ID: 185242
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated cytotoxicity to herpes-infected cells in humans: dependence on antibodies.
Moller-Larsen A; Heron I; Haahr S
Infect Immun; 1977 Apr; 16(1):43-7. PubMed ID: 194838
[TBL] [Abstract][Full Text] [Related]
4. Comparison of antibody-dependent cellular cytotoxicity and complement-dependent antibody lysis of herpes simplex virus-infected cells as methods of detecting antiviral antibodies in human sera.
Subramanian T; Rawls WE
J Clin Microbiol; 1977 Jun; 5(6):551-8. PubMed ID: 195975
[TBL] [Abstract][Full Text] [Related]
5. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. II. Identification as a K cell.
Melewicz FM; Shore SL; Ades EW; Phillips DJ
J Immunol; 1977 Feb; 118(2):567-73. PubMed ID: 65428
[TBL] [Abstract][Full Text] [Related]
6. Cell-mediated immunity to Herpes simplex in humans: lymphocyte cytotoxicity measured by 51-Cr release from infected cells.
Russell AS; Percy JS; Kovithavongs T
Infect Immun; 1975 Feb; 11(2):355-9. PubMed ID: 163220
[TBL] [Abstract][Full Text] [Related]
7. Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus.
Shore SL; Black CM; Melewicz FM; Wood PA; Nahmias AJ
J Immunol; 1976 Jan; 116(1):194-201. PubMed ID: 173757
[TBL] [Abstract][Full Text] [Related]
8. Antibody-dependent cellular protection against herpes simplex virus dissemination as revealed by viral plauqe and infectivity assays.
Shimizu F; Hanaumi K; Shimizu Y; Kumagai K
Infect Immun; 1977 May; 16(2):531-6. PubMed ID: 193792
[TBL] [Abstract][Full Text] [Related]
9. Protection of neonatal mice against herpes simplex virus infection: probable in vivo antibody-dependent cellular cytotoxicity.
Kohl S; Loo LS
J Immunol; 1982 Jul; 129(1):370-6. PubMed ID: 6282968
[TBL] [Abstract][Full Text] [Related]
10. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
[TBL] [Abstract][Full Text] [Related]
11. Cell-mediated cytotoxicity in recurrent herpes simplex virus infections in man.
Reichman RC; Dolin R; Vincent MM; Fauci AS
Proc Soc Exp Biol Med; 1977 Sep; 155(4):571-6. PubMed ID: 197538
[No Abstract] [Full Text] [Related]
12. Immune destruction of virus-infected cells early in the infectious cycle.
Shore SL; Cromeans TL; Romano TJ
Nature; 1976 Aug; 262(5570):695-6. PubMed ID: 183139
[No Abstract] [Full Text] [Related]
13. Humoral and cellular immune responses to an envelope-associated antigen of herpes simplex virus.
Zaia JA; Palmer EL; Feorino PM
J Infect Dis; 1975 Dec; 132(6):660-6. PubMed ID: 172562
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of human monocyte-macrophage and lymphocyte cytotoxicity to herpes simplex-infected cells by glucan.
Kohl S; Pickering LK; Diluzio NR
J Immunol Methods; 1979; 29(4):361-8. PubMed ID: 229165
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal Antibodies, Derived from Humans Vaccinated with the RV144 HIV Vaccine Containing the HVEM Binding Domain of Herpes Simplex Virus (HSV) Glycoprotein D, Neutralize HSV Infection, Mediate Antibody-Dependent Cellular Cytotoxicity, and Protect Mice from Ocular Challenge with HSV-1.
Wang K; Tomaras GD; Jegaskanda S; Moody MA; Liao HX; Goodman KN; Berman PW; Rerks-Ngarm S; Pitisuttithum P; Nitayapan S; Kaewkungwal J; Haynes BF; Cohen JI
J Virol; 2017 Oct; 91(19):. PubMed ID: 28701403
[TBL] [Abstract][Full Text] [Related]
16. The mononuclear cell in human blood which mediates antibody-dependent cellular cytotoxicity to virus-infected target cells. I. Identification of the population of effector cells.
Shore SL; Melewicz FM; Gordon DS
J Immunol; 1977 Feb; 118(2):558-66. PubMed ID: 190316
[TBL] [Abstract][Full Text] [Related]
17. Depressed specific cell-mediated immunity to Herpes simplex virus type 1 in patients with recurrent herpes labialis.
Thong YH; Vincent MM; Hensen SA; Fuccillo DA; Rola-Pleszczynski M; Bellanti JA
Infect Immun; 1975 Jul; 12(1):76-80. PubMed ID: 166930
[TBL] [Abstract][Full Text] [Related]
18. Cellular immune responses to Herpes simplex virus type 1 in recurrent herpes labialis: in vitro blastogenesis and cytotoxicity to infected cell line.
Steele RW; Vincent MM; Hensen SA; Fuccillo DA; Chapa IA; Canales L
J Infect Dis; 1975 May; 131(5):528-34. PubMed ID: 165245
[TBL] [Abstract][Full Text] [Related]
19. CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8
Srivastava R; Khan AA; Chilukuri S; Syed SA; Tran TT; Furness J; Bahraoui E; BenMohamed L
J Virol; 2017 Jul; 91(14):. PubMed ID: 28468883
[TBL] [Abstract][Full Text] [Related]
20. Immunological destruction of herpes simplex virus I infected cells.
Rager-Zisman B; Bloom BR
Nature; 1974 Oct; 251(5475):542-3. PubMed ID: 4371311
[No Abstract] [Full Text] [Related]
[Next] [New Search]
